1. Home
  2. ACHV vs HGLB Comparison

ACHV vs HGLB Comparison

Compare ACHV & HGLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Achieve Life Sciences Inc.

ACHV

Achieve Life Sciences Inc.

HOLD

Current Price

$4.59

Market Cap

172.0M

Sector

Health Care

ML Signal

HOLD

Logo Highland Global Allocation Fund

HGLB

Highland Global Allocation Fund

HOLD

Current Price

$7.96

Market Cap

178.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACHV
HGLB
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
172.0M
178.6M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
ACHV
HGLB
Price
$4.59
$7.96
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$14.67
N/A
AVG Volume (30 Days)
1.2M
72.1K
Earning Date
05-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$7.53
52 Week High
$6.15
$10.64

Technical Indicators

Market Signals
Indicator
ACHV
HGLB
Relative Strength Index (RSI) 48.02 35.25
Support Level $4.09 $7.74
Resistance Level $4.98 $9.06
Average True Range (ATR) 0.40 0.19
MACD -0.12 -0.02
Stochastic Oscillator 7.56 23.21

Price Performance

Historical Comparison
ACHV
HGLB

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.

About HGLB Highland Global Allocation Fund

Highland Global Allocation Fund is a diversified, closed-end management investment company. The investment objective of the Fund is to seek long-term growth of capital and future income. The Fund seeks to achieve its investment objectives by investing in a portfolio of U.S. and foreign equity, debt, and money market securities. It may also invest in senior loans to domestic or foreign corporations, partnerships, and other entities that operate in a variety of industries and geographic regions.

Share on Social Networks: